RT Journal Article SR Electronic T1 Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF JF Cancer Biology & Medicine JO Cancer Biology & Medicine FD China Anti-Cancer Association SP 945 OP 947 DO 10.20892/j.issn.2095-3941.2022.0299 VO 19 IS 7 A1 Wang, Hongquan A1 Wu, Shuang A1 Wang, Yan A1 Tang, Bo YR 2022 UL http://www.cancerbiomed.org/content/19/7/945.abstract AB